Clinical Trial Update: Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rituximab, zanubrutinib, and lenalidomide with subsequent maintenance in CNS lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Rituximab (rituximab)
• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Central Nervous System Lymphoma | Phase 2 | Status: UNKNOWN